Inhibition of iFGF23 signaling with rh-cFGF23 in CKD mice resulted in decreased erythroid cell apoptosis, upregulation of renal and BM HIF1α and subsequent EPO mRNA expression, elevated serum EPO levels and amelioration of iron deficiency. This evidence concerns the gene EPO and Iron deficiency anemia.